JPS58116414A - ニカルジピン持続性製剤用球形顆粒およびその製造法 - Google Patents

ニカルジピン持続性製剤用球形顆粒およびその製造法

Info

Publication number
JPS58116414A
JPS58116414A JP56208608A JP20860881A JPS58116414A JP S58116414 A JPS58116414 A JP S58116414A JP 56208608 A JP56208608 A JP 56208608A JP 20860881 A JP20860881 A JP 20860881A JP S58116414 A JPS58116414 A JP S58116414A
Authority
JP
Japan
Prior art keywords
nicardipine
composition
spherular
salt
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56208608A
Other languages
English (en)
Japanese (ja)
Other versions
JPS647047B2 (enExample
Inventor
Takashi Sonobe
尚 園部
Hiromitsu Kawada
川田　裕溢
Masayoshi Ariga
有賀　政義
Tadayoshi Omura
大村　忠義
Satoru Yonetani
悟 米谷
Chiharu Yamada
山田　千晴
Yukio Kubota
幸雄 久保田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP56208608A priority Critical patent/JPS58116414A/ja
Priority to MX82101116U priority patent/MX7567E/es
Priority to AT0460682A priority patent/AT386743B/de
Priority to CA000418228A priority patent/CA1200494A/en
Priority to GR70132A priority patent/GR77096B/el
Priority to IT68503/82A priority patent/IT1200966B/it
Priority to PT76023A priority patent/PT76023B/pt
Priority to ES518487A priority patent/ES518487A0/es
Priority to KR8205782A priority patent/KR860001147B1/ko
Publication of JPS58116414A publication Critical patent/JPS58116414A/ja
Priority to US07/013,326 priority patent/US4758437A/en
Priority claimed from US07/013,326 external-priority patent/US4758437A/en
Publication of JPS647047B2 publication Critical patent/JPS647047B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56208608A 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法 Granted JPS58116414A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP56208608A JPS58116414A (ja) 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法
MX82101116U MX7567E (es) 1981-12-23 1982-12-16 Procedimiento para recubrir nicardipina de accion prolongada
AT0460682A AT386743B (de) 1981-12-23 1982-12-20 Verfahren zur herstellung einer langwirkenden nicardipinzubereitung
CA000418228A CA1200494A (en) 1981-12-23 1982-12-21 Process of producing composition for long acting nicardipine preparation
GR70132A GR77096B (enExample) 1981-12-23 1982-12-21
IT68503/82A IT1200966B (it) 1981-12-23 1982-12-22 Composizione per preparati di nicardipina a lunga azione in forma di granuli sferici e procedimento per la produzione della composizione
PT76023A PT76023B (en) 1981-12-23 1982-12-22 A process of producing composition for long acting nicardipine preparation
ES518487A ES518487A0 (es) 1981-12-23 1982-12-22 Un procedimiento para producir una composicion para un preparado de accion prolongada de nicardipina.
KR8205782A KR860001147B1 (ko) 1981-12-23 1982-12-23 지속성 니카르디핀 제제용 조성물의 제조방법
US07/013,326 US4758437A (en) 1981-12-23 1987-02-11 Composition for long acting nicardipine preparation and process of producing the composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56208608A JPS58116414A (ja) 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法
US07/013,326 US4758437A (en) 1981-12-23 1987-02-11 Composition for long acting nicardipine preparation and process of producing the composition

Publications (2)

Publication Number Publication Date
JPS58116414A true JPS58116414A (ja) 1983-07-11
JPS647047B2 JPS647047B2 (enExample) 1989-02-07

Family

ID=26516929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56208608A Granted JPS58116414A (ja) 1981-12-23 1981-12-23 ニカルジピン持続性製剤用球形顆粒およびその製造法

Country Status (1)

Country Link
JP (1) JPS58116414A (enExample)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148114A (ja) * 1984-11-15 1986-07-05 Teijin Ltd ニフエジピンの顆粒剤
WO1986005393A1 (fr) * 1985-03-14 1986-09-25 Teysan Pharmaceuticals Co., Ltd. Preparation antibiotique granulaire composite stabilisee
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPS6470414A (en) * 1987-08-11 1989-03-15 Bayer Ag Dihydropyridine-containing continuous medicine
JPH01249718A (ja) * 1988-03-30 1989-10-05 Tomoaki Fukuda マイクロカプセルの製造方法
JPH01313431A (ja) * 1988-04-27 1989-12-18 Sanofi Sa ジルチアゼム・マイクロビーズ、その製法および徐放性医薬組成物
JPH01313427A (ja) * 1988-04-29 1989-12-18 Bayer Ag ジヒドロピリジン類を含有する徐放性製剤
JPH02705A (ja) * 1988-01-18 1990-01-05 Lek Tovarna Farmacevtskih ニカルジピン又はその塩酸塩のβ―シクロデキストリン包接複合体及びそれを含有する医薬製剤
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
EP0164959B1 (en) * 1984-06-04 1992-03-11 Sterwin Ag. Pharmaceutical composition in sustained release unit dose form and process for its preparation
WO1992018109A1 (en) * 1991-04-15 1992-10-29 Yamanouchi Pharmaceutical Co., Ltd. Rapidly soluble solid preparation
JP2000080028A (ja) * 1998-07-17 2000-03-21 Dev Center For Biotechnol 長持続時間を有するシサプリドの経口剤形
JP2000229888A (ja) * 1999-02-10 2000-08-22 Pfizer Prod Inc マトリックス制御放出デバイス
JP2003503341A (ja) * 1999-06-28 2003-01-28 サノフィ−サンテラボ 少なくとも一つの適時パルスを生ずる制御された放出用の医薬投与形態

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5587717A (en) * 1978-12-05 1980-07-02 Haessle Ab Cardiotonic glycoside containing medicine
DE3024858A1 (de) * 1979-07-05 1981-01-22 Yamanouchi Pharma Co Ltd Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5587717A (en) * 1978-12-05 1980-07-02 Haessle Ab Cardiotonic glycoside containing medicine
DE3024858A1 (de) * 1979-07-05 1981-01-22 Yamanouchi Pharma Co Ltd Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164959B1 (en) * 1984-06-04 1992-03-11 Sterwin Ag. Pharmaceutical composition in sustained release unit dose form and process for its preparation
JPS61148114A (ja) * 1984-11-15 1986-07-05 Teijin Ltd ニフエジピンの顆粒剤
WO1986005393A1 (fr) * 1985-03-14 1986-09-25 Teysan Pharmaceuticals Co., Ltd. Preparation antibiotique granulaire composite stabilisee
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPS6470414A (en) * 1987-08-11 1989-03-15 Bayer Ag Dihydropyridine-containing continuous medicine
JPH02705A (ja) * 1988-01-18 1990-01-05 Lek Tovarna Farmacevtskih ニカルジピン又はその塩酸塩のβ―シクロデキストリン包接複合体及びそれを含有する医薬製剤
JPH01249718A (ja) * 1988-03-30 1989-10-05 Tomoaki Fukuda マイクロカプセルの製造方法
JPH01313431A (ja) * 1988-04-27 1989-12-18 Sanofi Sa ジルチアゼム・マイクロビーズ、その製法および徐放性医薬組成物
JPH01313427A (ja) * 1988-04-29 1989-12-18 Bayer Ag ジヒドロピリジン類を含有する徐放性製剤
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
WO1992018109A1 (en) * 1991-04-15 1992-10-29 Yamanouchi Pharmaceutical Co., Ltd. Rapidly soluble solid preparation
US5624687A (en) * 1991-04-15 1997-04-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-dissolution solid preparation
JP2000080028A (ja) * 1998-07-17 2000-03-21 Dev Center For Biotechnol 長持続時間を有するシサプリドの経口剤形
JP2000229888A (ja) * 1999-02-10 2000-08-22 Pfizer Prod Inc マトリックス制御放出デバイス
JP2005320354A (ja) * 1999-02-10 2005-11-17 Pfizer Prod Inc マトリックス制御放出デバイス
JP2003503341A (ja) * 1999-06-28 2003-01-28 サノフィ−サンテラボ 少なくとも一つの適時パルスを生ずる制御された放出用の医薬投与形態

Also Published As

Publication number Publication date
JPS647047B2 (enExample) 1989-02-07

Similar Documents

Publication Publication Date Title
JP2560019B2 (ja) 活性化合物の放出を制御する新規な製剤およびその製造法
EP3137060B2 (en) Extended release suspension compositions
ES2428064T3 (es) Sistemas de liberación pulsátil controlada
KR0156038B1 (ko) 방출 조절 모르핀 제제
US6627223B2 (en) Timed pulsatile drug delivery systems
RU2548748C2 (ru) Композиции, включающие слабоосновные лекарственные вещества, и лекарственные формы с контролированным высвобождением
JP2003504324A (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
PL188834B1 (pl) Farmaceutyczne formulacje zawierające tramadol lub jego fizjologicznie akceptowane sole oraz sposóbwytwarzania tych formulacji
ES2303238T3 (es) Preparacion granulada de liberacion lenta que contiene una droga con estructura de amina con base en particulas con una capa de recubrimiento y el correspondiente metodo de produccion.
US4758437A (en) Composition for long acting nicardipine preparation and process of producing the composition
KR19980070732A (ko) 항균 활성 퀴놀론 유도체의 풍미 차폐성 제제의 제조방법
JPS647047B2 (enExample)
JP3221891B2 (ja) 咀嚼可能な製薬錠剤調製のための回転造粒及び味覚遮蔽被覆加工
PL192950B1 (pl) Wielocząstkowa postać farmaceutyczna o opóźnionym i stopniowym uwalnianiu, oraz sposób jej wytwarzania
JPH0451528B2 (enExample)
JP2000053563A (ja) 苦味がマスクされた速放性細粒剤
JPH10502358A (ja) 作用物質の遊離遅延を伴うカルバマゼピン薬剤
CN101754754A (zh) 含有包覆的含药物的颗粒的可分散药片及其制备方法
JP2000212085A (ja) オメプラゾ―ル又はその他類似物を含有する高安定性経口医薬製剤及びその製法
CA2685214C (en) Improved controlled release oral dosage form
ES2376095B1 (es) Pellets entéricos de duloxetina.
JPS63267720A (ja) エモルフアゾンの徐放性製剤
JP3505734B2 (ja) エカベトナトリウム含有経口投与用製剤
EP2808019B1 (en) Improved nitazoxanide composition and preparation method thereof
ES2221140T3 (es) Procedimiento para formar composiciones farmaceuticas en pildoras o granulos esfericos de accion controlada y sostenida que contienen bromazepam como agente activo y composiciones farmaceuticas obtenidas por dicho procedimiento.

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
R154 Certificate of patent or utility model (reissue)

Free format text: JAPANESE INTERMEDIATE CODE: R154